Results 121 to 130 of about 4,798 (243)

<i>Ex Vivo</i> Therapeutic Base and Prime Editing Using Chemically Derived Hepatic Progenitors in a Mouse Model of Tyrosinemia Type 1

, 2020
Yohan Kim, Jihyeon Yu, Sung-Ah Hong, Jeongyun Eom, Kiseok Jang, Seu-Na Lee, Jae‐Sung Woo, Jaemin Jeong, Sangsu Bae, Dongho Choi   +9 more
openalex   +1 more source

Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended [PDF]

, 2011
P D’Eufemia, Mauro Celli, Martina Tetti, Roberto Finocchiaro   +3 more
openalex   +1 more source

Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. [PDF]

Genet Med, 2017
Chinsky JM, Singh R, Ficicioglu C, van Karnebeek CDM, Grompe M, Mitchell G, Waisbren SE, Gucsavas-Calikoglu M, Wasserstein MP, Coakley K, Scott CR.   +10 more
europepmc   +1 more source

Silent tyrosinemia type I with normal succinylacetone presenting as hepatocellular carcinoma in a paediatric patient [PDF]

Jean-Marco Verdi, Paola Carolina Espin, Michelle Bao, Swati Antala   +3 more
openalex   +1 more source

Cost-Consequence Analysis of Nitisinone for Treatment of Tyrosinemia Type I. [PDF]

Can J Hosp Pharm, 2015
Simoncelli M, Samson J, Bussières JF, Lacroix J, Dorais M, Battista R, Perreault S.   +6 more
europepmc   +1 more source

Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I

, 1998
Marı́a-José Prieto-Álamo, Françoise Laval   +1 more
openalex   +1 more source

Self-induced correction of the genetic defect in tyrosinemia type I. [PDF]

, 1994
E. A. Kvittingen, Helge Rootwelt, Ruud Berger, P Brandtzæg   +3 more
openalex   +1 more source

TYPE I HEREDITARY TYROSINEMIA: CHARACTERIZATION OF HUMAN cDNA CLONES ENCODING PEPTIDES IMMUNE-REACTING WITH ANTIBODIES AGAINST FUMARYLACETOACETASE FROM BEEFLIVER [PDF]

, 1987
Etienne Agsteribbe, Henk van Faassen, Thérèse Reversma, Jan‐Willem Taanman, Hans Pannekoek, C L Verweij, Ralf G. Berger   +6 more
openalex   +1 more source

CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I. [PDF]

JHEP Rep
Chen T, Barzi M, Furey N, Kim HR, Pankowicz FP, Legras X, Elsea SH, Hurley AE, Yang D, Wheeler DA, Borowiak M, Bissig-Choisat B, Sumazin P, Bissig KD.   +13 more
europepmc   +1 more source

Pediatric Hepatology: A three-year experience with pediatric liver transplantation with cyclosporine and steroids [PDF]

, 1986
Gartner, JC, Iwatsuki, S, Malatack, JJ, Shaw, BW, Starzl, TE, Urbach, AH, Zitelli, BH   +6 more
core